PanCAN and our national grassroots community of advocates led the charge to create the first-ever Pancreatic Cancer Research Program (PCARP) at the Department of Defense (DoD) in 2019. That year, ...

If you’re interested in trying a BCAA supplement, our dietitians rounded up the eight best. General price ranges with dollar signs ($ to $$$) are indicated below. One dollar sign means the ...

Despite alcohol's harmful effects, many people still consume it socially. Neuroscientist Robert Love suggests supplements like activated charcoal to reduce alcohol absorption, selenium for ...

The state of our guts is so revealing about our health. Stress, illness, anxiety can all manifest in our stomachs. “It affects how susceptible we are to a range of things such as inflammatory ...

Herbs and supplements may help, but research is generally older, limited, and lacking in long-term results. Fibromyalgia is a chronic disorder. Symptoms can include fatigue, brain fog, and ...

Dwaraka from TruDiagnostic, studied how a natural anti-aging supplement called the Cel System might influence the aging process. They found that participants who took the supplement for one year ...

Australian rock band Midnight Oil’s drummer and founding member Rob Hirst has been battling pancreatic cancer for about two years, after he was diagnosed with the disease “early” when it was stage ...

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, with only 12% of patients surviving 5 years after diagnosis. Several elements of the PDAC tumor microenvironment ...

Pancreatic cysts are fluid-filled sacs that can form in the pancreas. Some remain benign, while others have the potential to develop into pancreatic cancer. A recent study, which followed 257 ...

Pancreas divisum is the most common pancreatic disorder that develops before birth. This congenital condition affects less than 10% of people, but only about 5% experience symptoms. Usually, a case of ...

nutrition supplements and anti-diabetics medicines. The state drug controllers have also been asked to review their approval process for such fixed dose combination (FDC) drugs, and ensure strict ...

Namodenoson targets the A3 adenosine receptor, showing promise in trials for pancreatic and liver cancers, and has orphan drug designation for rare diseases. A phase 2a trial in Israel and the U.S.